Fantastic real world application of the financial implications of the #ETC model - what’s the dollar amount of the penalties/bonuses? By the wonderful Terry Ketchersid at #RPA22
And with these numbers personally the relevance of #ETC drops significantly.
What about JV owners? The monetary amounts are bigger but is it enough to drive investment and change practice? I don’t think so. The dialysis companies have more to risk so may drive the response to ETC. Nephrologists need to be at the center!
How do you earn back the 5% quality withhold in the #CKCC? By achieving in these 3 measures. Seriously, this talk is great. Value of #RPA22 registration just in these 45 minutes.
When looking at your #VBC partnership, make sure you know where all the #CKCC revenue streams are going. #RPA22
CKCC bottom line - lots of assumptions built in, YMMV, but great to have some idea of what you can expect. #RPA22
There are other revenue streams in CKCC besides the CKD capitated quarterly payments! Here’s slide 2 of projected revenue:
“The levers or success are simple… in ETC you’re already doing these.” -Terry Ketchersid #RPA22 Pay attention to the dementia diagnosis!
RPA members should access our #VBC guidance document on our website to learn the pros and cons of partnering with a company. #RPA22
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Lessons from #RPA22 which just wrapped up in Dallas, a 🧵 1) Value-based care (#VBC) has injected a jolt of energy into the private practice sphere. Half the exhibitors on the convention floor were new since 2019. It was THE topic of conversation during the breaks - who are you
working with, have you signed up with anyone? The 3/25 deadline for KCE participation added to the frenzy, as did news of the Cricket-Interwell-Fresenius merger. Talks about VBC and the new payment models were well attended and garnered lots of questions and discussion.
2) The mandatory #ETC model is a dead letter, at least on the nephrologist side. For all but the big practices, the dollars at risk are too small, and the performance results too long delayed, to warrant making any changes. The dialysis companies have more $ at risk, but it was
Nephrologists: we need to prepare to stop our routine CKD and HTN clinic visits. I've been diving into options for #telehealth. I am by no means an expert but here's what I've learned. Would love more experienced people to chime in. A thread: 1/n
Disclaimer: I'm in private practice and I'm thinking about revenue. I'm committed to paying my staff their full salaries plus paid sick leave throughout this, and I expect to stay closed for two months. It would help to have some income coming in. 2/n
We can and should debate the structure of the US healthcare system another time. For now, I want to protect my patients, not have a six month backlog in clinic when we reopen, and keep the lights on. 3/n